Si se confirma, esto representara un cambio fundamental en la forma en que la sociedad entiende la adiccin y en cmo la tratan los mdicos
Guedes GB, et al
The study, conducted by partner Medix in Mexico, demonstrated an average weight loss of 10% over 24 weeks, with more than half of the patients achieving a weight loss of over 10%
Reports contain similar claims of GI side effects, particularly in off-label or long-term users
Stopping or interrupting GLP-1 receptor agonists erode and could ultimately reverse their cardiovascular benefits, increasing the risk for major adverse cardiovascular events, researchers wrote in BMJ Medicine
However, worth noting, Retatrutide remains a research compound only , it isnt approved for any therapeutic use, and all comparisons refer strictly to pre-clinical research findings